US Patent 11857512 Pharmaceutical compositions comprising venglustat
Patent 11857512 was granted and assigned to Genzyme on January, 2024 by the United States Patent and Trademark Office.
All edits
Edits on 3 Jan, 2024
Golden AI
Edits made to:
Infobox (+54 properties)
Article (+420 characters)
US Patent 11857512 Pharmaceutical compositions comprising venglustat
Article
Patent abstract
The present disclosure relates to pharmaceutical compositions, including dosage forms, such as tablets or capsules, comprising venglustat, in free base, or pharmaceutically acceptable salt form, a diluent/filler and a lubricant, optionally in combination with one or more additional therapeutic agents, to processes for manufacture thereof, and to methods of use in the treatment or prevention of disease.
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
Patent Inventor Names
Audrey Jeanjean0
Chris Ho0
Danielle Combessis0
David Rigal0
Pankaj Taneja0
Date of Patent
January 2, 2024
0Patent Application Number
173840830
Date Filed
July 23, 2021
0Patent Citations
Patent Primary Examiner
Find more entities like US Patent 11857512 Pharmaceutical compositions comprising venglustat
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
